Cargando…
Blood-Based Biomarkers: A Forgotten Friend of Hyperacute Ischemic Stroke
Ischemic stroke (IS) is the second leading cause of death worldwide. Multimodal neuroimaging techniques that have significantly facilitated the diagnosis of hyperacute IS are not widely used in underdeveloped areas and community hospitals owing to drawbacks such as high cost and lack of trained oper...
Autores principales: | Liu, Zhilan, Yang, Cui, Wang, Xiaoming, Xiang, Yang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217611/ https://www.ncbi.nlm.nih.gov/pubmed/34168606 http://dx.doi.org/10.3389/fneur.2021.634717 |
Ejemplares similares
-
Editorial: Blood-Based Biomarkers in Acute Ischemic Stroke and Hemorrhagic Stroke
por: Uphaus, Timo, et al.
Publicado: (2022) -
Significance of Vertigo, Imbalance, and Other Minor Symptoms in Hyperacute Treatment of Posterior Circulation Stroke
por: Kim, Min, et al.
Publicado: (2022) -
Hyperacute stroke thrombolysis via telemedicine: a multicentre study of performance, safety and clinical efficacy
por: Evans, Nicholas Richard, et al.
Publicado: (2022) -
Plasma mid‐regional pro‐adrenomedullin: A biomarker of the ischemic penumbra in hyperacute stroke
por: Ishiyama, Hiroyuki, et al.
Publicado: (2022) -
Impaired Nutritional Condition After Stroke From the Hyperacute to the Chronic Phase: A Systematic Review and Meta-Analysis
por: Huppertz, Viviënne, et al.
Publicado: (2022)